Interventions to mitigate cancer‐related medical financial hardship: A systematic review and meta‐analysis
Top Cited Papers
Open Access
Abstract
Background: This study systematically reviewed interventions mitigating financial hardship in patients with cancer and assessed effectiveness using a meta‐analytic method.Methods: PubMed, Cochrane, Scopus, CINAHL, and Web of Science were searched for articles published in English during January 2000–April 2023. Two independent reviewers selected prospective clinical trials with an intervention targeting and an outcome measuring financial hardship. Quality appraisal and data extraction were performed independently by two reviewers using a quality assessment tool. A random‐effects model meta‐analysis was performed. Reporting followed the preferred reporting items for systematic review and meta‐analyses guidelines.Results: Eleven studies (2211 participants; 55% male; mean age, 59.29 years) testing interventions including financial navigation, financial education, and cost discussion were included. Financial worry improved in only 27.3% of 11 studies. Material hardship and cost‐related care nonadherence remained unchanged in the two studies measuring these outcomes. Four studies (373 participants; 37% male, mean age, 55.88 years) assessed the impact of financial navigation on financial worry using the comprehensive score of financial toxicity (COST) measure (score range, 0–44; higher score = lower financial worry) and were used for meta‐analysis. There was no significant change in the mean of pooled COST score between post‐ and pre‐intervention (1.21; 95% confidence interval, –6.54 to 8.96; p = .65). Adjusting for pre‐intervention COST, mean change of COST significantly decreased by 0.88 with every 1‐unit increase in pre‐intervention COST (p = .02). The intervention significantly changed COST score when pre‐intervention COST was ≤14.5.Conclusion: A variety of interventions have been tested to mitigate financial hardship. Financial navigation can mitigate financial worry among high‐risk patients.Keywords
This publication has 34 references indexed in Scilit:
- Patient-Reported Financial Burden of Treatment for Colon or Rectal CancerJAMA Network Open, 2024
- The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communicationPEC Innovation, 2022
- Necessity for and Limitations of Price Transparency in American Health CareAMA Journal of Ethics, 2022
- Association of Health Insurance Literacy With Financial Hardship in Patients With CancerJAMA Network Open, 2022
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statementJournal of Clinical Epidemiology, 2021
- Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategiesJournal of Surgical Oncology, 2019
- Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)Cancer, 2016
- The development of a financial toxicity patient‐reported outcome in cancer: The COST measureCancer, 2014
- Random-effects model for meta-analysis of clinical trials: An updateContemporary Clinical Trials, 2007
- Improved tests for a random effects meta‐regression with a single covariateStatistics in Medicine, 2003